Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis-Reference-Cited by-同舟云学术

Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis

Published:2019-10-04 Issue:6 Volume:46 Page:565-576
ISSN:1567-567X
Container-title:Journal of Pharmacokinetics and Pharmacodynamics
language:en
Short-container-title:J Pharmacokinet Pharmacodyn

Author:

Alhadab Ali A.^ORCID, ,Rhein Joshua,Tugume Lillian,Musubire Abdu,Williams Darlisha A.,Abassi Mahsa,Nicol Melanie R.,Meya David B.,Boulware David R.,Brundage Richard C.

Funder

National Center for Advancing Translational Sciences of the National Institute of Health Award

National Institute of Neurological Disorders and Stroke

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s10928-019-09657-0.pdf

Reference52 articles.

1. Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, Denning DW, Loyse A, Boulware DR (2017) Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 17:873–881. https://doi.org/10.1016/S1473-3099(17)30243-8Elsevier

2. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. Aids 23:525–530. https://doi.org/10.1097/QAD.0b013e328322ffac

3. Rhein J, Morawski BM, Hullsiek KH, Nabeta HW, Kiggundu R, Tugume L, Musubire A, Akampurira A, Smith KD, Alhadab A, Williams DA, Abassi M, Bahr NC, Velamakanni SS, Fisher J, Nielsen K, Meya DB, Boulware DR, Ndyetukira JF, Ahimbisibwe C, Kugonza F, Sadiq A, Kandole TK, Luggya T, Kaboggoza J, Laker E, Butler EK, Dyal J, Neborak JM, King AM, Fujita AW, Yueh N, Namudde A, Halupnick R, Jawed B, Vedula P, Peterson M, Bohjanen PR, Kambugu A (2016) Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study. Lancet Infect Dis 16:809–818. https://doi.org/10.1016/S1473-3099(16)00074-8

4. Boulware DR, Meya DB, Muzoora C, Rolfes MA, Huppler Hullsiek K, Musubire A, Taseera K, Nabeta HW, Schutz C, Williams DA, Rajasingham R, Rhein J, Thienemann F, Lo MW, Nielsen K, Bergemann TL, Kambugu A, Manabe YC, Janoff EN, Bohjanen PR, Meintjes G (2014) Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med 370:2487–2498. https://doi.org/10.1056/NEJMoa1312884

5. Jarvis JN, Bicanic T, Loyse A, Namarika D, Jackson A, Nussbaum JC, Longley N, Muzoora C, Phulusa J, Taseera K, Kanyembe C, Wilson D, Hosseinipour MC, Brouwer AE, Limmathurotsakul D, White N, Van Der Horst C, Wood R, Meintjes G, Bradley J, Jaffar S, Harrison T (2014) Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis 58:736–745. https://doi.org/10.1093/cid/cit794

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of modeling and simulation to improve the treatment of fungal infections caused by Cryptococcus : A literature review;Brazilian Journal of Pharmaceutical Sciences;2024

2. Halal Alternative Formulation to Enhance Sertraline/Fluconazole Antifungal Activity and Minimize Drug Side Effect in Cryptococcus meningitis;Solving Halal Industry Issues Through Research in Halal Sciences;2024

3. The Antidepressant Sertraline Induces the Formation of Supersized Lipid Droplets in the Human Pathogen Cryptococcus neoformans;Journal of Fungi;2022-06-17

4. The need for an integrated pharmacological response to the treatment of HIV/AIDS and depression;Expert Opinion on Pharmacotherapy;2021-02-13

5. Adjunctive sertraline for asymptomatic cryptococcal antigenemia: A randomized clinical trial;Medical Mycology;2020-05-16